Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of clopidogrel after percutaneous coronary intervention
ChiCTR-TRC-12002167Phase 4Completed
- Sponsor
- Xinhua Hospital
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of clopidogrel in coronary arteriosclerosis (2 arms), sponsored by Xinhua Hospital. Primary endpoints: Clopidogrel resistance and CYP2C19 gene polymorphism. Started Feb 2012; status: completed.
02
Drugs
clopidogrel
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR-TRC-12002167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002167.